Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, NewAmsterdam Pharma Company NV (NASDAQ: NAMS) closed at $23.70 up 0.64% from its previous closing price of $23.55. In other words, the price has increased by $0.64 from its previous closing price. On the day, 0.94 million shares were traded. NAMS stock price reached its highest trading level at $24.09 during the session, while it also had its lowest trading level at $23.17.
Ratios:
For a deeper understanding of NewAmsterdam Pharma Company NV’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.61 and its Current Ratio is at 10.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.Scotiabank initiated its Sector Outperform rating on March 14, 2024, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 10 ’25 when NAP PoolCo B.V. bought 1,396,241 shares for $25.31 per share.
ForGrowth NAP B.V. sold 29,846 shares of NAMS for $762,174 on Dec 30 ’24. The 10% Owner now owns 10,656,172 shares after completing the transaction at $25.54 per share. On Dec 27 ’24, another insider, ForGrowth NAP B.V., who serves as the 10% Owner of the company, sold 41,472 shares for $25.95 each. As a result, the insider received 1,076,290 and left with 10,686,018 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAMS now has a Market Capitalization of 2537156096 and an Enterprise Value of 1767322112. Its current Enterprise Value per Revenue stands at 52.608 whereas that against EBITDA is -9.602.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $27.29, while it has fallen to a 52-week low of $15.19. The 50-Day Moving Average of the stock is 0.57%, while the 200-Day Moving Average is calculated to be 19.61%.
Shares Statistics:
For the past three months, NAMS has traded an average of 816.48K shares per day and 553120 over the past ten days. A total of 92.17M shares are outstanding, with a floating share count of 60.55M. Insiders hold about 43.32% of the company’s shares, while institutions hold 35.60% stake in the company. Shares short for NAMS as of 1735603200 were 2967626 with a Short Ratio of 3.63, compared to 1732838400 on 2588991. Therefore, it implies a Short% of Shares Outstanding of 2967626 and a Short% of Float of 4.22.
